EUVIMEDObjevte EUVIMED
Open access · CC BY 4.0

Xanthatin‐13‐(Pyrrolidine‐2‐Carboxylic Acid), a Sesquiterpene Lactone Isolated From Burdock Leaf, Attenuated Aβ 25‐35 Toxicity and Memory Deficits in a Pharmacological Mouse Model of Alzheimer's Disease

Charlyne Barry-Simonnet iD, Lucie Crouzier iD, Tristan Moujellil-Legagneur iD, Hamza Chaieb-Errass, Yanis A Idres iD, Karine Ferrare iD, Marc Rolland iD, Guillaume Cazals iD, Patrick Poucheret iD, Tangui Maurice iD, Didier Tousch iD

Phytotherapy Research · 2026

DOI: 10.1002/ptr.70294 ↗

At a glance

Journal article in Phytotherapy Research, 2026. Written by Charlyne Barry-Simonnet and 10 co-authors. Institution: MMDN, Univ Montpellier, EPHE, INSERM, Montpellier, France. Major MEDLINE topics: Amyloid beta-Peptides, Alzheimer Disease, Memory Disorders, Peptide Fragments. 76 references. The full text is freely available (open access, CC BY 4.0). Funded by: Université de Montpellier.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Alzheimer's disease (AD) is a severe form of dementia, which occurrence increases with age and lifestyle conditions. It is characterized by amyloid protein accumulation forming senile plaques, hyperphosphorylated tau protein forming neurofibrillary tangles, neuroinflammation, and oxidative stress, leading to synapse loss and cell death. Pharmacological alternatives to conventional treatments include alkaloids with anti‐inflammatory and antioxidant properties. Sesquiterpene lactones, such as Xanthatin‐13‐(pyrrolidine‐2‐carboxylic acid) (XPc) from burdock leaf, show promise due to their antioxidant activity targeting glucose‐6‐phosphate dehydrogenase. This study evaluated XPc's protective effects in vivo using Aβ 25‐35 ‐treated mice, a pharmacological AD model, and explores its synergistic potential with neuroprotective agents like TSPO activators or sigma‐1 receptor agonists. Mice were administered Aβ 25‐35 peptide (9 nmol ICV) and XPc (0.3–3 mg/kg) daily for 4 days. Behavioral tests assessed memory deficits and anxiety. Post‐sacrifice, brains were analyzed for neuroinflammation and oxidative stress markers. Combination studies involved XPc with the TSPO activator PK11195 or the sigma‐1 receptor agonist PRE‐084, with memory evaluated in two behavioral tests. Combination indices were calculated to assess synergy. XPc (1–3 mg/kg) prevented Aβ 25‐35 ‐induced memory impairments and anxiety. It reduced astroglial reaction, blocked microglial activation, and confirmed antioxidant activity by lowering lipid peroxidation and protein nitrosylation. Combinations with PK11195 or PRE‐084 showed synergistic protection in memory tests. XPc is a potent neuroprotective agent against AD‐like toxicity in this murine model, effective alone or in synergistic combinations with other drugs.

Subjects

MeSH terms (MEDLINE)

Amyloid beta-PeptidesAlzheimer DiseaseMemory DisordersPeptide FragmentsSesquiterpenesLactonesPyrrolidinesAnimalsMiceDisease Models, AnimalMaleNeuroprotective AgentsOxidative StressPlant LeavesReceptors, sigmaSigma-1 ReceptorAntioxidantsBrain

Author keywords

anti‐amnesiadrug combinationneuroinflammationneuroprotectionoxidative stresssesquiterpene alkaloid

Substances

Amyloid beta-PeptidesPeptide FragmentsSesquiterpenesamyloid beta-protein (25-35)Neuroprotective AgentsReceptors, sigmaLactonesPyrrolidinesSigma-1 ReceptorAntioxidants

Authors and institutions

  • MMDN, Univ Montpellier, EPHE, INSERM, Montpellier, France.
  • Qualisud, Univ Montpellier, CIRAD, Institut Agro, Univ Avignon, Univ La Réunion, Montpellier, France.
  • IEM, Univ Montpellier, CNRS, ENSCM, Montpellier, France.
  • PAC Chimie-Balard, Univ Montpellier, CNRS, ENSCM, Montpellier, France.

ORCID profiles: Charlyne Barry-Simonnet, Lucie Crouzier, Tristan Moujellil-Legagneur, Yanis A Idres, Karine Ferrare, Marc Rolland, Guillaume Cazals, Patrick Poucheret, Tangui Maurice, Didier Tousch

Funding

  • Université de Montpellier

Cite

APA

Barry-Simonnet, C., Crouzier, L., Moujellil-Legagneur, T., Chaieb-Errass, H., Idres, Y. A., Ferrare, K., Rolland, M., Cazals, G., Poucheret, P., Maurice, T., & Tousch, D. (2026). Xanthatin‐13‐(Pyrrolidine‐2‐Carboxylic Acid), a Sesquiterpene Lactone Isolated From Burdock Leaf, Attenuated Aβ 25‐35 Toxicity and Memory Deficits in a Pharmacological Mouse Model of Alzheimer's Disease. Phytotherapy Research. https://doi.org/10.1002/ptr.70294

Vancouver

Barry-Simonnet C, Crouzier L, Moujellil-Legagneur T, Chaieb-Errass H, Idres YA, Ferrare K, et al. Xanthatin‐13‐(Pyrrolidine‐2‐Carboxylic Acid), a Sesquiterpene Lactone Isolated From Burdock Leaf, Attenuated Aβ 25‐35 Toxicity and Memory Deficits in a Pharmacological Mouse Model of Alzheimer's Disease. Phytotherapy Research. 2026. doi:10.1002/ptr.70294

BibTeX
@article{BarrySimonnet2026,
  author = {Barry-Simonnet, Charlyne and Crouzier, Lucie and Moujellil-Legagneur, Tristan and Chaieb-Errass, Hamza and Idres, Yanis A and Ferrare, Karine and Rolland, Marc and Cazals, Guillaume and Poucheret, Patrick and Maurice, Tangui and Tousch, Didier},
  title = {Xanthatin‐13‐(Pyrrolidine‐2‐Carboxylic Acid), a Sesquiterpene Lactone Isolated From Burdock Leaf, Attenuated Aβ 25‐35 Toxicity and Memory Deficits in a Pharmacological Mouse Model of Alzheimer's Disease},
  journal = {Phytotherapy Research},
  year = {2026},
  doi = {10.1002/ptr.70294}
}
Start for free →